  See all
 |
Articles: Renal/Urologic |
Prior Articles
Prognostic Significance of Hydronephrosis in Bladder Cancer Treated by Radical Cystectomy
Urologia Internationalis, 10/20/09
Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer
Clinical Cancer Research, 10/19/09 Location of the Primary Tumor is Not an Independent Predictor of Cancer Specific Mortality in Patients With Upper Urinary Tract Urothelial Carcinoma
The Journal of Urology, 10/19/09 Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09 Treating the individual: The need for a patient-focused approach to the management of renal cell carcinoma
Cancer Treatment Reviews, 10/15/09 New treatment approaches in renal cell carcinoma
Anti-Cancer Drugs, 10/15/09 Differential expression of the semaphorin 3A pathway in prostatic cancer
Histopathology, 10/15/09 Medical history, body size, and cigarette smoking in relation to fatal prostate cancer
Cancer Causes and Control, 10/14/09 High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors
Annals of Oncology, 10/14/09 Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Revew Article
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09 Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort
Cancer Causes and Control, 10/13/09 Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate
Cancer Cell, 10/12/09 Genoproteomic Mining of Urothelial Cancer Suggests gamma-Glutamyl Hydrolase and Diazepam-Binding Inhibitor as Putative Urinary Markers of Outcome after Chemotherapy
American Journal of Pathology, 10/12/09 Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: The Sparc trial
Journal of Clinical Oncology, 10/08/09 A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer
Investigational New Drugs, 10/08/09
Free full text
Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases
Human Pathology, 10/08/09 AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K
Oncogene, 10/08/09 NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth
Investigational New Drugs, 10/08/09 Inhibition of constitutive and cxc-chemokine-induced NF-kappaB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells
British Journal of Cancer, 10/08/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
